India · Delayed Price · Currency is INR EPL Limited Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 17.6% in Q4, led by 30% growth in beauty and cosmetics and double-digit gains across all regions. The proposed Indovida merger is expected to be margin accretive, while robust cash flow and disciplined capital allocation support ongoing growth and resilience.
-
A transformational merger will create a $1B packaging leader in emerging markets, combining rigid and flexible formats, with strong financials, $35–50M in annual synergies, and a diversified global footprint. Regulatory approvals are expected within 12 months.
-
Revenue grew 13.3% year-over-year with strong double-digit gains in beauty and cosmetics, which now comprise over half the portfolio. EBITDA margin remained robust at 20.1%, and ROCE improved to 18.7%, while Europe faced short-term operational challenges.
-
Double-digit revenue and profit growth were driven by strong performance in beauty and cosmetics, with Americas and EAP leading regional gains. Margins expanded, sustainability credentials improved, and new capacity in Thailand and Brazil supports future growth.
-
Double-digit revenue and EBITDA growth were driven by strong performance in Europe, Americas, and beauty and cosmetics, with margin expansion and improved capital efficiency. Strategic investments, capacity expansions, and sustainability initiatives support continued growth, while oral care recovery is expected in H2.
Fiscal Year 2025
-
Q4 and FY25 delivered strong revenue, EBITDA, and PAT growth, with robust margin expansion and improved cash flow. Beauty and cosmetics led segment growth, supported by capacity expansions and sustainability initiatives. Double-digit growth and margin improvement are targeted for FY26.
-
Delivered 10th consecutive quarter of margin expansion and double-digit EBITDA growth, with strong performance in Europe, Americas, and BNC. Greenfield expansion in Thailand and Brazil capacity increase target high-growth beauty and cosmetics markets. EBITDA margin reached 20.3%, and ROC improved to 16.9%.
-
Q2 FY25 delivered strong growth with revenue up 8.4%, EBITDA up 19.7%, and PAT up 72% year-over-year. Europe led with 21% growth, and the Personal Care & Beyond segment rose 10.2%. Sustainability initiatives advanced, with recyclable products at 33% of the mix.
-
Double-digit revenue and EBITDA growth were achieved, with margin expansion and strong performance across all regions. Sustainability initiatives and innovation drove wallet share gains, especially in oral care, while Brazil's modular plant ramped up faster than expected.